FML StartUp hemotune raises CHF 5.1 million Series A funding
hemotune raises CHF 5.1 million Series A funding to accelerate the development of their disruptiveblood purification platform
external pagehemotune, a spin-off from our laboratories, founded in 2017 announced the closing of a CHF 5.1 million Series A to advance the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads. Despite the corona crisis, hemotune managed to build a very strong consortium led by OCCIDENT with participation of the Korean medical device company Greencross Medical Science Corp. (GCMS), and Zürcher Kantonalbank.